Kelly Miller
Company: Quanterix
Job title: Director of Strategic Collaborations
Seminars:
Ultrasensitive Biomarkers for Neurodegenerative Disease: Clinical and Diagnostic Advances 11:15 am
New translational ultrasensitive biomarkers that can help define and categorize neurodegenerative diseases. Use in clinical trials and Dx applications Performance characteristics of Simoa-based LDT testing programs utilizing ultrasensitive neurodegeneration biomarkers Analytical and clinical sensitivity of Alzheimer’s disease blood-based biomarkers (pTau217 and Multimarker panels)Read more
day: Conference Day One